Angelico Carta, MD
Angelico Carta, President and co-founder of Worldwide Clinical Trials, is responsible for global sales and corporate growth and development. As one of Worldwide’s co-founders, he has been instrumental in shepherding the organization through its growth from a clinician-led, patient-focused research center into its current status as a key global provider of drug development services. He has overseen Worldwide’s strategic growth in Europe and continues to lead expansion into emerging markets in the Middle East, Africa, Asia-Pacific, and Latin America.
ABOUT ANGELICO CARTA, MD
Dr. Carta has more than 20 years’ experience in the international pharmaceutical industry and CRO management. Early in his career, Dr. Carta’s leadership experience included a position as Senior Director and Head of Clinical Research within a large global pharmaceutical company, encompassing Phase II–III trials across CNS, cardiovascular, and endocrinology. Dr. Carta’s vision, combined with that of three like-minded individuals of long association, Dr. Neal Cutler, Dr. Neil Kurtz, and Dr. Michael Murphy, led to the founding of Worldwide Clinical Trials in the mid 1990s. Within four years under Dr. Carta’s direction, the growth of ex-US operations into a multimillion-dollar enterprise spanned 25 countries.
Dr. Carta also served for four years as President of Global Business Initiatives for a global pharmaceutical company. Subsequently, he became Managing Director of a private pharmaceutical development consultancy specializing in CNS drug development services, with multiple global pharmaceutical and CRO customers to its credit.
Dr. Carta is the first or co-author of over 30 papers on clinical neuropsychopharmacology published in internationally renowned journals. Additionally, he has co-authored six reference texts on the clinical development of Alzheimer’s disease, antipsychotic drugs, and CNS drug development. Dr. Carta continues to present and review clinical data at numerous clinical neurology and neuropsychiatry meetings internationally. He is a board-certified neurologist and holds an M.D. from the University of Rome, School of Medicine, with training in neurology from King’s College Hospital in London.